[A multicenter comparative study in patients with liver metastasis to compare tegafur in new forms with existing drugs. SF-RC.SF-SP Comparative Study Group].

A multicenter comparative study was carried out in 101 patients with liver metastasis to compare tegafur in a new oral form (Sunfural S) and tegafur in a new soft-capsule suppository form (Sunfural Rectal Capsules) with existing drugs. Sunfural S showed a tendency toward high plasma and tissue levels as compared to existing drugs, and clinically, Sunfural S produced survival times that surpassed those of existing drugs. Liver metastasis at the present time has few effective treatments, but we expect that anticancer effects will be obtained through the administration of new drugs with improved bioavailability.
AuthorsA Kashii, H Kogure
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 16 Issue 7 Pg. 2387-92 (Jul 1989) ISSN: 0385-0684 [Print] JAPAN
PMID2502074 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, English Abstract, Journal Article, Multicenter Study)
Chemical References
  • Capsules
  • Suppositories
  • Tegafur
  • Administration, Oral
  • Adult
  • Aged
  • Aged, 80 and over
  • Biological Availability
  • Capsules
  • Colonic Neoplasms
  • Female
  • Humans
  • Liver (metabolism)
  • Liver Neoplasms (drug therapy, metabolism, secondary)
  • Male
  • Middle Aged
  • Multicenter Studies as Topic
  • Stomach Neoplasms
  • Suppositories
  • Tegafur (administration & dosage, pharmacokinetics, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: